title: Assessment of the robustness of volumetric-modulated arc therapy for lung radiotherapy.
abstract: Volumetric-modulated arc therapy (VMAT) is increasingly popular as a treatment method in radiotherapy owing to the speed with which treatments can be delivered. However, there has been little investigation into the effect of increased modulation in lung plans with regard to interfraction organ motion. This is most likely to occur where the planning target volume (PTV) lies within areas of low density. This paper aims to investigate the effect of modulation on the dose distribution using simulated patient movement and to propose a method that is less susceptible to such movement. Simulated interfraction motion is achieved by moving the plan isocentre in steps of 0.5 cm and 1.0 cm in six directions for five clinical VMAT patients. The proposed planning method involves optimisation using a density override of 1 g cm(-3), within the PTV in lung, to reduce segment boosting in the periphery of the PTV. This investigation shows that modulation can result in an increase in the maximum dose of >25%, an increase in PTV near-maximum dose of 17% and a reduction in near-minimum dose by 46%. Unacceptable organ at risk (OAR) doses are also seen. The proposed method reduces modulation, resulting in a maximum dose increase of 10%. Although safeguards are in place to prevent the increased dose to OARs from patient movement, there is nothing to prevent the increased dose as a result of modulation in lung. A simple planning method is proposed to safeguard against this effect. Investigation suggests that, where modulation exists in a plan, this method reduces it and is clinically viable.
authors: The Royal Marsden NHS Foundation Trust, Sutton, UK. Katie.Edmunds@rmh.nhs.uk
authors: K
authors: K
authors: Edmunds
authors: J
authors: J
authors: Bedford
mesh_terms: D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D009068:Movement; D059351:Organ Sparing Treatments / Q000592:standards; D058958:Organs at Risk / Q000528:radiation effects; D010347:Patient Care Planning; D011879:Radiotherapy Dosage; D050397:Radiotherapy, Intensity-Modulated / Q000592:standards*
references: Radiother Oncol. 2007 Dec;85(3):346-54
references: 17967493
references: Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e251-6
references: 22365622
references: Radiat Oncol. 2011 Oct 21;6:140
references: 22014217
references: Int J Cancer. 2001 Dec 20;96(6):379-84
references: 11745509
references: J Thorac Oncol. 2011 Mar;6(3):531-6
references: 21258244
references: Med Phys. 2009 Nov;36(11):5128-38
references: 19994523
references: Acta Oncol. 2008;47(7):1438-43
references: 18654906
references: Clin Oncol (R Coll Radiol). 2012 Feb;24(1):68-75
references: 21396808
references: Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1560-7
references: 21300461
references: Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):369-75
references: 20800379
references: Acta Oncol. 2010 Oct;49(7):1077-84
references: 20831499